Provided by Tiger Trade Technology Pte. Ltd.

ADMA Biologics

10.36
+0.03000.29%
Post-market: 10.360.00000.00%19:30 EDT
Volume:2.83M
Turnover:29.25M
Market Cap:2.32B
PE:14.79
High:10.51
Open:10.32
Low:10.25
Close:10.33
52wk High:20.46
52wk Low:7.21
Shares:223.98M
Float Shares:210.51M
Volume Ratio:0.92
T/O Rate:1.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7004
EPS(LYR):0.6000
ROE:41.90%
ROA:21.78%
PB:5.68
PE(LYR):17.27

Loading ...

Dec 20, 2024

Major Issues Report

Form 8-K - Current report
Nov 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2024

Major Issues Report

Form 8-K - Current report
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Oct 31, 2024

Major Issues Report

Form 8-K - Current report
Oct 17, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 10, 2024

Major Issues Report

Form 8-K - Current report
Oct 09, 2024

Major Issues Report

Form 8-K - Current report
Sep 23, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sep 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2024

Major Issues Report

Form 8-K - Current report
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Jul 26, 2024

Major Issues Report

Form 8-K - Current report